Skip to Content

'
Joseph L. Nates, M.D., M.B.A, F.C.C.M.

Present Title & Affiliation

Primary Appointment

Professor, Department of Critical Care, Division of Anesthesiology and Critical Care, The University of Texas MD Anderson Cancer Center, Houston, TX
Deputy Department Chair, Department of Critical Care, Division of Anesthesiology and Critical Care, The University of Texas MD Anderson Cancer Center, Houston, TX

Office Address

The University of Texas MD Anderson Cancer Center
1515 Holcombe Blvd.
Unit Number: Unit 112
Houston, TX 77030
Room Number: B7.4340
Phone: (713) 563-1365
Fax: (713) 745-1869

Education & Training

Degree-Granting Education

2005 California Pacific University, Escondido, CA, MBA, MBA-HCA
1981 Universidad del Norte, Barranquilla, Colombia, MD, Doctor of Medicine

Board Certifications

1/2003 Advanced Cardiac Life Support (ACLS)
7/1999 ECFMG Certification
1/1992 Advanced Trauma Life Support (ATLS)

Honors and Awards

2014 Presidential Citation, for outstanding contributions to the Society of Critical Care Medicine, Society of Critical Care Medicine
2012-2015 Multi-Year Appointment Award, The University of Texas M.D. Anderson Cancer Center
2012 Dr. Joseph and Rae Brown Award, Society of Critical Care Medicine
2012 Honorable Mention for Achievement in Eliminating Central Line Associated Bloodstream Infections, MD Anderson Cancer Center
2012 Outstanding Achievement and Leadership Elimination of Ventilator-Associated Pneumonia, U.S. Department of Health and Human Services and Critical Care Societies Collaborative
2011-present The Alfred Soffer Award for Research (Senior author in study), American College of Chest Physicians
2011-present The American Society of Parenteral and Enteral Nutrition (Senior author in study), American Society of Parenteral and Enteral Nutrition
2011-2012 Presidential Citation for outstanding contributions to the Society of Critical Care Medicine, Society of Critical Care Medicine
2011 Bill Aston Award for Quality, Texas Hospital Association
2011 Dr. Joseph and Rae Brown Award, Society of Critical Care Medicine
2011 Project "Decreasing Ventilator Days in the Medical Intensive Care Unit", UT System Building Bridges Conference, San Antonio, TX
2010-2011 Chapters and Affiliants Alliance Excellence Award, Society of Critical Care Medicine
2010 Clinical Safety and Effectiveness Award, The University of Texas System
2010 Presidential Citation, Society of Critical Care Medicine
2009-2012 Multi-Year Appointment Award, The University of Texas M.D. Anderson Cancer Center
2009 American College of Critical Care, "Sepsis Award" for research in catheter-related blood stream infections, Society of Critical Care
2009 Presidential Citation, Society of Critical Care Medicine
2009 Sepsis Award, American College of Critical Care
2009 The 2009 Sepsis Specialty Award, Society of Critical Care Medicine
2009 The Nobuo-Maeda International Research Award by the Gerontological Section of the American Public Health Association for our work focused in palliative care and end-of-life issues in Latin America for the study titled "Demographic, clinical, and economic factors associated with the place of death of participants in the Mexican Health and Aging Study" Senior Author, American Public Health Association
2008-2010 The Leadership Award, The Texas Chapter of the Society of Critical Care Medicine (SCCM)
2008-2009 Elected President of Texas Chapter of the Society of Critical Care Medicine
2006-2009 Multi-Year Appointment Award, The University of Texas M.D. Anderson Cancer Center

Professional Memberships

American Association of Respiratory Care (AARC)
Member, 2003-present
American Society of Anesthesiology (ASA)
Member, 1994-present
American Society of Critical Care Anesthesiologists (ASCCA)
Member, 2002-present
American Thoracic Society (ATS), TX
Member, 2005-present
SCCM for Latino-America Education
Executive Committee, 2013-present
Texas Society of Anesthesiologists (TSA), TX
Member, 1997-present

Selected Publications

Peer-Reviewed Original Research Articles

1. Warkentin TE, Sheppard JA, Heels-Ansdell D, Marshall JC, McIntyre L, Rocha MG, Mehta S, Davies AR, Bersten AD, Crozier TM, Ernest D, Vlahakis NE, Hall RI, Wood GG, Poirier G, Crowther MA, Cook DJ, Canadian Critical Care Trials Group, Australian and New Zealand Intensive Care Society Clinical Trials Group. Heparin-induced thrombocytopenia in medical surgical critical illness. Chest 144(3):848-58, 9/2013. PMID: 23722881.
2. Lauzier F, Arnold DM, Rabbat C, Heels-Ansdell D, Zarychanski R, Dodek P, Ashley BJ, Albert M, Khwaja K, Ostermann M, Skrobik Y, Fowler R, McIntyre L, Nates JL, Karachi T, Lopes RD, Zytaruk N, Finfer S, Crowther M, Cook D. Risk factors and impact of major bleeding in critically ill patients receiving heparin thromboprophylaxis. Intensive Care Med, 8/2013. PMID: 23942857.
3. Price KJ, Cardenas-Turanzas M, Lin H, Roden L, Nigam R, Nates JL. Prognostic indicators of mortality of mechanically ventilated patients with acute leukemia in a comprehensive cancer center. Minerva Anestesiol 79(2):147-55, 2/2013. e-Pub 10/2012. PMID: 23032926.
4. Smith OM, McDonald E, Zytaruk N, Foster D, Matte A, et.al. Rates and determinants of informed consent: a case study of an international thromboprophylaxis trial. J Crit Care 28(1):28-39, 2/2013. PMID: 23089679.
5. Lauzier F, Arnold D, Rabbat C, Heels-Ansdell D, Dodek P, Ashley B, Albert M, Khwaja K, Ostermann M, Skrobik Y, Fowker R, McIntyre L, Nates J, Karachi T, Lopes R, Zytaruk N, Crowther M, Cook D. Major bleeding in medical-surgical critically ill patients is associated with increased use of blood products, longer hospital stay and higher mortality. Intensive Care Medicine. e-Pub 1/2013.
6. Cardenas-Turanzas M, Ensor J, Wakefield C, Zhang K, Wallace SK, Price KJ, Nates JL. Cross-validation of a Sequential Organ Failure Assessment score-based model to predict mortality in patients with cancer admitted to the intensive care unit. Journal of Critical Care 27(6):673-80, 12/2012. e-Pub 7/2012. PMID: 22762932.
7. Samuels J, Ng CS, Nates J, Price K, Finkel K, Salahudeen A, Shaw A. Small increases in serum creatinine are associated with prolonged ICU stay and increased hospital mortality in critically ill patients with cancer. Support Care Cancer 19(10):1527-32, 10/2011. e-Pub 8/15/2010. PMCID: PMC3037438.
8. Fu S, Hong DS, Naing A, Wheler J, Falchook G, Wen S, Howard A, Barber D, Nates J, Price K, Kurzrock R. Outcome analyses after the first admission to an intensive care unit in patients with advanced cancer referred to a phase I clinical trials program. J Clin Oncol 29(26):3547-52, 9/10/2011. e-Pub 8/15/2011. PMID: 21844494.
9. Nates JL, Cárdenas-Turanzas M, Ensor J, Wakefield C, Wallace SK, Price KJ. Cross-validation of a modified score to predict mortality in cancer patients admitted to the intensive care unit. Society of Critical Care Medicinie 26(4):388-94, 8/2011. e-Pub 12/2010. PMID: 21195582.
10. Lahoti A, Nates JL, Wakefield CD, Price KJ, Salahudeen AK. Costs and Outcomes of Acute Kidney Injury in Critically Ill Patients with Cancer. J Support Oncol 9(4):149-55, Jul-Aug, 7/2011. PMID: 21809520.
11. Cárdenas-Turanzas M, Torres-Vigil I, Tovalín-Ahumada H, Nates JL. Hospital versus Home Death: Results from the Mexican Health and Aging Study. J Pain Symptom Manage 41(5):880-92, 5/2011. e-Pub 12/2010. PMID: 21146354.
12. Ramos ER, Reitzel R, Jiang Y, Hachem RY, Chaftari AM, Chemaly RF, Hackett B, Pravinkumar SE, Nates J, Tarrand JJ, Raad II. Clinical effectiveness and risk of emerging resistance associated with prolonged use of antibiotic-impregnated catheters: more than 0.5 million catheter days and 7 years of clinical experience. Crit Care Med 39(2):245-51, 2/2011. PMID: 21057308.
13. Cardenas-Turanzas M, Gaeta S, Ashoori A, Price KJ, Nates JL. Demographic and clinical determinants of having do not resuscitate orders in the intensive care unit of a comprehensive cancer center. J Palliat Med 14(1):45-50, 1/2011. e-Pub 12/2010. PMID: 21194303.
14. Chen K, Puana RB, Price KJ, Koller CA, Nates JL. The Role of Point-of-Care Testing in the Early Diagnosis of Pseudo-Hypoxemia in Myeloproliferative Disorders. Respir Care 55(6):777-9, 6/2010. PMID: 20507664.
15. Nates JL, Cárdenas-Turanzas M, Wakefield C, Kish Wallace S, Shaw A, Samuels JA, Ensor J, Price KJ. Automating and simplifying the SOFA score in critically ill patients with cancer. Health Informatics J 16(1):35-47, 3/2010. PMID: 20413411.
16. Cardenas-Turanzas M, Cesta MA, Wakefield C, Wallace SK, Puana R, Price KJ, Nates JL. Factors associated with anemia in patients with cancer admitted to an intensive care unit. J Crit Care 25(1):112-9, 3/2010. e-Pub 7/3/2009. PMID: 19577413.
17. Cesta MA, Cardenas-Turanzas M, Wakefield C, Price KJ, Nates JL. Life-supportive therapy withdrawal and length of stay in a large oncologic intensive care unit at the end of life. J Palliat Med 12(8):713-8, 8/2009. PMID: 19586391.
18. Salahudeen AK, Kumar V, Madan N, Xiao L, Lahoti A, Samuels J, Nates J, Price K. Sustained low efficiency dialysis in the continuous mode (C-SLED): dialysis efficacy, clinical outcomes, and survival predictors in critically ill cancer patients. Clin J Am Soc Nephrol 4(8):1338-46, 8/2009. e-Pub 7/23/2009. PMCID: PMC2723965.
19. Pirat A, Tucker AM, Taylor KA, Jinnah R, Finch CG, Canada TD, Nates JL. Comparison of Measured versus preducted energy requirements in critically ill cancer patients. Respir Care 54(4):487-94, 4/2009. PMID: 19327184.

Abstracts

1. Turanzas-Cardenas Marylou, Malik Imrana, Ravandi Farhad, Borthakur Gautham, Cortes Jorge, Kantarjian Hagop, Price Kristen J, Nates Joseph L. Sepsis in Acute Myeloid Leukemia: A Population Level Study in Texas. Society of Critical Care Medicine 43nd Critical Care Congress (#1076), 2014.
2. Crommett JW, Nates JL, Ferson D, Young P. Mass of Luminal Secretion: Comparison Between Pneux and PVC Tracheal Tubes. Critical Care Medicine, Supplement 40(12) (#1051), 12/2012.
3. Rathi Nisha, Tanner Anne Rain, Dong Wenli, Yadav Menaka, Feng Lei, Wallace Susannah, Price Kristen, Nates Joseph, Haque Sadid. Aminocaproic Acid combined with high dose Methylprednisolone may not improve outcomes in critically ill cancer patients with diffuse alveolar hemorrhage. Society of Critical Care Medicine 42nd Critical Care Congress, 10/2012.
4. McLenon M, Nates J, de Villalobos Diego. Aortoesophageal Fisutla: Two Endovascular Case Studies and a Review of the Literature. Society of Critical Care Medicine 42nd Critical Care Congress (#6815), 10/2012.
5. Nates JL, Jordan V. Decision Support for Patients Flow Management and Performance Improvement in the Intensive Care Unit. The University of Texas System Systems Engineering in Healthcare Conference, 10/2012.
6. Arnold D, Lauzier F, Rabbat C, Heels-Ansdell D, Dodek P, Ashley B, Albert M, Khwaja K, Ostermann M, Skrobik Y, Fowler R, McIntyre L, Nates J, Karachi T, Lopes R, Zytaruk N, Crowther M, Cook D. In Medical-Surgical ICU Patients, major bleeding is common but independent of Heparin Prophylaxis. Critical Care 16(Suppl 1):435, 3/2012.
7. Lauzier F, Arnold D, Rabbat C, Heels-Ansdell D, Dodek P, Ashley B, Albert M, Khwaja K, Ostermann M, Skrobik Y, Fowker R, McIntyre L, Nates J, Karachi T, Lopes R, Zytaruk N, Crowther M, Cook D. Major bleeding in medical-surgical critically ill patients is associated with increased use of blood products, longer hospital stay and higher mortality. Critical Care Medicine, 2012.
8. Bayraktar UD, Shpall EJ, Liu P, Ciurea SO, Rondon G, de Lima M, Price KJ, Champlin RE, Nates JL. Hematopoietic Cell Transplantation-Specific Comorbidity Index (HCT-CI) as a Predictor of Mortality in Allogeneic Transplant Patients Admitted to Intensive Care Unit. American Society of Hematology (#147), 12/2011.
9. Rathi N, Dinh A, Feng L, Dong W, Liu S, Haque S, Price K, Nates JL. Outcomes of High Dose Steroid Treatment with or without Aminocaproic Acid in Critically Ill Stem Cell Transplant Recipients with Diffuse Alveolar Hemorrhage. Accepted for presentation at the American Society of Hematology Annual Meeting, 12/2011.
10. Rathi N, Haque S, Feng L, Price K, Nates JL. Variability of ICU Triage Practices in a Cancer Hospital. Critical Care Medicine, Supplement 39(12) (#604), 12/2011.
11. Zarychanski R, Lauzier F, Turgeon A, Marshall J, Nates JL, Cox M, Arabi Y, Qushmaq I, Zytaruk N. VTE Risk Factors in Medical-Surgical ICU Patients. Critical Care Medicine 39(12)(Suppl) (#A672), 12/2011.
12. Rathi N, Dinh A, Feng L, Dong W, Liu S, Haque S, Hovedn M, Price K, Nates JL. Aminocaproic Acid Does Not Reduce Mortailty in Cancer Patients with Diffuse Alveolar Hemorrhage. CHEST, Honolulu, Hawaii, October 22-26, 2011 140(4)(Meeting Abstracts 203A), 10/2011.
13. Nates JL, Rathi N, Haque S, Gaeta S, Pravinkumar E, Botz G, Chen K, Crommett J, Calabrese D, Villalobos D, Malik I, Price K. ICU Triage Improves Patient Flow and Resource Utilization. CHEST, Honolulu, Hawaii, October 22-26, 2011 140(4)(Meeting Abstracts 357A), 10/2011.
14. Haque S, Dinh A, Rathi N, Feng L, Owen M, Lange G, Price K, Nates JL. Thrombocytopenia Does Not Protect from Deep Vein Thrombosis in Critically Ill Cancer Patients. CHEST Honolulu, Hawaii, October 22-26,2011 140(4)(Meeting Abstracts 878A), 10/2011.
15. Nates JL. Ventilator-Associated Pneumonia: Is it Over Yet, or Can I Still Do Something to Prevent It?. CHEST 2011, Honolulu, HI, October 22-26, 2011, 10/2011.
16. McLenon M, Nates J. Thromboprophylaxis in Critically Ill Cancer Patients: Where is the Evidence? A Systematic Review. MASCC (#836), 6/2011.
17. Lahoti A, Nates JL, Samuels J, Wakefield C, Price K, Salahudeen A. Acute Kidney Injury as Defined by the RIFLE Classification Has Prognostic Utility in Critically Ill Patients With Cancer. Critical Care Medicine 35 (12)(Suppl Meeting Abstract 865):A240, 12/2007.
18. Nates JL, Finch C, Frederick F, Berkehiser M, Lee L, Pravinkumar E, Price K. Environmental Sampling During High Frequency Ventilation in Critically Ill Cancer Patients. Critical Care Medicine 35 (12)(Meeting Abstracts A88), 12/2007.
19. Chen K, Burdine C, Botz G, Nates JL. Financial Impact of ICU Point-of-Care Electronic Professional Charge Capture. Critical Care Medicine 35 (12)(Suppl Abstract A107), 12/2007.
20. Bruno J, Canada T, Wakefield C, Nates JL. Gastrointestinal bleeding in critically ill cancer patients receiving stress ulcer prophylaxis. Critical Care Medicine 35(12) (#A704(Suppl)), 2007.
21. Nates JL, Cesta MA, Wakefield C, Price K. Withdrawal of life sustaining therapy does not reduce length- of -stay in critically ill leukemia patients. 20th ESICM Congress Meeting, 2007.

Last updated: 3/25/2014